Exagen Inc. XGN Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s share-based payment award options outstanding - number?
- Exagen Inc. (XGN) reported share-based payment award options outstanding - number of 706.8K in Q1 2026.
- How has Exagen Inc.'s share-based payment award options outstanding - number changed year-over-year?
- Exagen Inc.'s share-based payment award options outstanding - number increased by 16.2% year-over-year, from 608.1K to 706.8K.
- What is the long-term trend for Exagen Inc.'s share-based payment award options outstanding - number?
- Over 5 years (2020 to 2025), Exagen Inc.'s share-based payment award options outstanding - number has grown at a -23.2% compound annual growth rate (CAGR), from 2M to 526.8K.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.